[Federal Register Volume 74, Number 177 (Tuesday, September 15, 2009)]
[Notices]
[Pages 47264-47265]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-22014]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel T32 SEP Review.
    Date: October 5, 2009.
    Time: 5 p.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Robert Bird, PhD, Chief, Resources and Training 
Review Branch, Division of Extramural Activities, National Cancer 
Institute, 6116 Executive Boulevard, Room 8113, Bethesda, MD 20892-
8328, 301-496-7978, <a href="/cdn-cgi/l/email-protection#d5b7bca7b1a795b8b4bcb9fbbbbcbdfbb2baa3"><span class="__cf_email__" data-cfemail="d5b7bca7b1a795b8b4bcb9fbbbbcbdfbb2baa3">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Discovery and Development.
    Date: October 6-7, 2009.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington DC/Rockville, Hotel & Executive Meeting 
Center, 1750 Rockville Pike, Hollow Square, Rockville, MD.
    Contact Person: Peter J. Wirth, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, 6116 Executive Boulevard, Room 8131, 
Bethesda, MD 20892-8328, 301-496-7565, <a href="/cdn-cgi/l/email-protection#6414135615240a0d0c4a030b12"><span class="__cf_email__" data-cfemail="a4d4d396d5e4cacdcc8ac3cbd2">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Innovative Technology Development for Cancer Research (R21).
    Date: October 14, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5701 Marinelli Road, Bethesda, MD 
20852.
    Contact Person: Jeffrey E. DeClue, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8059, Bethesda, MD 20892-8329, 301-496-7904, 
<a href="/cdn-cgi/l/email-protection#264243454a53434c664b474f4a08484f4e08414950"><span class="__cf_email__" data-cfemail="0b6f6e68677e6e614b666a626725656263256c647d">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Clinical Studies.
    Date: October 14-15, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Majed M. Hamawy, M.B.A., PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8135, Bethesda, MD 20852, 301-594-5659, 
<a href="/cdn-cgi/l/email-protection#0865603938397e48666160266f677e"><span class="__cf_email__" data-cfemail="0e63663f3e3f784e60676620696178">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Molecular Oncology--Basic, Translational and Clinical 
Studies.
    Date: October 19-20, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington DC/Rockville, Executive Meeting Center, 
1750 Rockville Pike, Rockville, MD 20852.
    Contact Person: Michael B. Small, PhD, Scientific Review 
Officer, Division of

[[Page 47265]]

Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Blvd., Room 8127, Bethesda, MD 
20892-8328, 301-402-0996, <a href="/cdn-cgi/l/email-protection#d3a0beb2bfbfbe93beb2babffdbdbabbfdb4bca5"><span class="__cf_email__" data-cfemail="9eedf3fff2f2f3def3fff7f2b0f0f7f6b0f9f1e8">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 3, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-22014 Filed 9-14-09; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>